Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) Stock

About Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. operates as an investment holding enterprise deeply embedded in China's pharmaceutical and healthcare industries. The company oversees a full range of activities, from the research and development of new drugs to their manufacturing, nationwide distribution, and retail sales of a diverse array of pharmaceutical and health-related products. Its operations are strategically managed across four primary divisions: Production, Distribution, Retail, and Other services. The company's extensive product catalog includes chemical compounds, biochemicals, traditional Chinese remedies, general healthcare items, and medical devices. These offerings are designed to address a broad spectrum of medical conditions, encompassing oncology, cardiovascular and cerebrovascular issues, central nervous system disorders, general infections, immunological diseases, digestive and metabolic ailments, and respiratory conditions. Notably, their portfolio boasts over 700 distinct pharmaceutical formulations. Beyond product development and manufacturing, Shanghai Pharmaceuticals is a significant player in comprehensive pharmaceutical supply chain management. This involves sophisticated distribution, warehousing, logistics, and various value-added services, all provided to a wide range of clients including drug manufacturers and healthcare providers such as hospitals, other wholesalers, and individual retail pharmacies. Moreover, the company maintains a substantial retail footprint, managing an extensive network of roughly 2,000 chain pharmacies spread across 24 provinces, alongside a thriving online drug commerce platform. Its diverse service offerings further extend to consulting, asset management, facilitating clinical trials, offering medical assistance, educating both medical professionals and patients, handling electronic prescriptions, and pioneering remote and cloud-based hospital solutions. Established in Shanghai in 1994, Shanghai Pharmaceuticals Holding Co., Ltd. functions as a subsidiary under Shanghai Pharmaceutical (Group) Co., Ltd.

Shanghai Pharmaceuticals Holding Co., Ltd is headquartered in CN.

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMY) stock trades at $7.34 with a market capitalization of $5.44B. The stock is valued at a price-to-earnings (P/E) ratio of 10.56, price-to-book of 0.80, price-to-sales of 0.21. Over the past 52 weeks the stock has ranged between $7.07 and $8.32, and currently trades 11.8% below its 52-week high. It pays a dividend yielding 6.95%.

On profitability, Shanghai Pharmaceuticals Holding Co., Ltd generates a return on equity (ROE) of 7.64%, return on capital employed of 10.29%, an operating margin of 3.53%, a net profit margin of 2.02%.

Official website: www.sphchina.com